Nicox completes the acquisition of Aciex Therapeutics, Inc.

October 27, 2014

Sophia Antipolis, France.
Nicox S.A. (NYSE Euronext Paris: COX) today announced the completion of the acquisition of Aciex Therapeutics, Inc., a private, US-based, ophthalmic development pharmaceutical company. This acquisition represents a significant step forward in Nicox’s strategy of creating an international ophthalmic company and will significantly broaden and strengthen Nicox’s therapeutic development pipeline.
For more information, please refer to:

← Back to blog page